Daily FNArena News

Following the exit of the major banks from wealth management, specialist providers have stepped up but are likely to endure several years of increasing competition in price and technology.

Amcor has upgraded guidance and announced a new buyback, providing a pleasing outlook for the rest of FY21.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

During October the ASX200 outperformed most developed markets peers, with the financial and technology sectors leading the way

Performance fees at JO Hambro made a welcome return for Pendal Group at the end of FY20 and continued delivery of stronger net flows could be the necessary re-rating catalyst.

Heightened interest in infection prevention should be of benefit to Nanosonics in the wake of the pandemic, although rising cases in the short term create risks.

Preparing for the “green recovery” and social stimulus, ESG investors are focusing on the effects of covid-19 on individual environmental, social and governance themes, and lining up their ducks – FNArena summarises the winners and losers and checks out the post-covid geopolitical and anti-trust environments

McPherson’s has expanded into the herbal product segment by acquiring Global Therapeutics and can now build out that business across its pharmacy distribution channel.

Brambles has a defensive business with a dominant global position and is now more confident in the FY21 outlook.

The Chartist suggests WTI crude may be in for a bit more upside but warns only short term traders should take the risk.